Mary Fidler to Follow-Up Studies
This is a "connection" page, showing publications Mary Fidler has written about Follow-Up Studies.
Connection Strength
0.241
-
The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer. 2018 03 20; 18(1):310.
Score: 0.102
-
Congophilic Fibrillary Glomerulonephritis: A Case Series. Am J Kidney Dis. 2018 09; 72(3):325-336.
Score: 0.026
-
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int. 2018 07; 94(1):159-169.
Score: 0.026
-
Membranous nephropathy with crescents: a series of 19 cases. Am J Kidney Dis. 2014 Jul; 64(1):66-73.
Score: 0.019
-
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy. Pract Radiat Oncol. 2014 Sep-Oct; 4(5):342-348.
Score: 0.019
-
Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2013 Jul; 14(4):370-5.
Score: 0.018
-
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney. Nephrol Dial Transplant. 2012 Mar; 27(3):1097-101.
Score: 0.016
-
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
Score: 0.015